Home › Metastatic Cancer › NCT06165419
Definitive Radiation for High-Risk Spine Metastases
RecruitingPhase 2
A Phase II Study Evaluating Definitive Radiosurgical Decompression in Patients With High-Risk Spinal Metastases
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Eligible patients must have: * Any pathologically proven solid tumor diagnosis not of central nervous system origin with radiographic or pathologic evidence of metastatic disease * Metastatic spine involvement documented by imaging * Involvement of maximum 3 contiguous vertebral bodies at the index site * Intact neurologic function, or only minor neurologic deficits with muscle strength greater or equal to 4 out of 5 with or without steroids * An evaluation by an radiation oncology and orthopedic spine/neurosurgery attending * ECOG Performance Status of 0-3 Patients are ineligible if they have: * An unstable spine defined as a Spinal Instability Neoplastic Score (SINS) greater than 12 * Had previous surgery or radiation to address the target spinal metastases * Radiosensitive tumors (e.g. small cell lung cancer, lymphoma, multiple myeloma, and germ-cell tumors)
About the study
This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only and avoid a large spine surgery
What is being tested
- SBRT to the spine (radiation)
Sponsor: Stony Brook University · Participants: 26 · Started: Dec 14, 2023
Contact the study team
- Hermina Munoz, RN · Phone: 631-216-2990
- Lucia Joya · Phone: 631-216-2998
Official record on ClinicalTrials.gov — NCT06165419
Locations in the U.S.
| New York | Stony Brook University Hospital, Stony Brook |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.